Replies to post #5875 on Amarantus Bioscience Holdings Inc (AMBS)

[Sir Francelote]

Agree! This one is for the mid-long term. I have all the time in the world!

[SOCOM]

It won't be very long. A new 8k was posted today!

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8902691

SOCOM

MM76

[Goldstrike]

Good advice. Just this one piece of news from two days ago says it all about where this company is headed: "Amarantus BioSciences, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced that it has appointed Amgen Co-Founder Joseph Rubinfeld, PhD to its Corporate Advisory Board. Dr. Rubinfeld will assist management in positioning the Company's development programs for partnering, as well as provide guidance on MANF-based small molecule strategies with his extensive medicinal chemistry background.
"I believe in MANF," said Dr. Rubinfeld, "I have reviewed a great number of technologies in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen."
This is the real thing folks. Divorce yourself from emotion and the message board riff-raff. Know what you own.

[IPO$]

I hope they do not RS in 6 months though.